U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H25ClN2O3
Molecular Weight 340.845
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETICLOPRIDE

SMILES

CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Cl)=CC(CC)=C2O

InChI

InChIKey=AADCDMQTJNYOSS-LBPRGKRZSA-N
InChI=1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H25ClN2O3
Molecular Weight 340.845
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Eticlopride {2S(−)-3-chloro-5-ethyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-hydroxy-2-methoxybenzamide} is an antagonist at dopamine D2 and D3 receptors. It is widely used for in vivo, in vitro, and ex vivo examination of D2/D3 receptors densities and function. Eticlopride exerts antipsychotic activity in animals.

CNS Activity

Curator's Comment: Eticlopride is CNS active in animals. No human data available.

Originator

Sources: de Paulis T, Hall H, Ogren SO, Wagner A. Synthesis, crystal structure and antidopaminergic properties of eticlopride (FLB 131) Eur J Med Chem. 1985;29:273–276

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.5 nM [Ki]
0.16 nM [Ki]
Target ID: P14416
Gene ID: 1813.0
Gene Symbol: DRD2
Target Organism: Homo sapiens (Human)
0.08 nM [Ki]
Target ID: P35462
Gene ID: 1814.0
Gene Symbol: DRD3
Target Organism: Homo sapiens (Human)
0.134 nM [Ki]
7.0 null [pKi]
PubMed

PubMed

TitleDatePubMed
Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
1994 Jan
Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
1994 Jan 1
Is clozapine selective for the dopamine D4 receptor?
1995
Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown.
1996 Jul 22
Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway.
1997 Apr 25
Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats.
1997 Jun
Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions.
1999 Jan 1
Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
2002 Apr 1
Effects of dopamine antagonists on alfentanil-induced locomotor activity in horses.
2003 Jul
Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus.
2004 Mar 24
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
2005 Aug
Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior.
2006 Oct 23
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:28:45 GMT 2023
Edited
by admin
on Fri Dec 15 16:28:45 GMT 2023
Record UNII
J8M468HBH4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ETICLOPRIDE
INN  
INN  
Official Name English
eticlopride [INN]
Common Name English
(-)-(S)-5-CHLORO-3-ETHYL-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-6-METHOXYSALICYLAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66883
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
Code System Code Type Description
WIKIPEDIA
ETICLOPRIDE
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
PUBCHEM
57267
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
CAS
84226-12-0
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
NCI_THESAURUS
C65572
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
DRUG BANK
DB15492
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
FDA UNII
J8M468HBH4
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
EVMPD
SUB07296MIG
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
ChEMBL
CHEMBL8946
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
EPA CompTox
DTXSID9048435
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
SMS_ID
100000082052
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
MESH
C045989
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
INN
5641
Created by admin on Fri Dec 15 16:28:45 GMT 2023 , Edited by admin on Fri Dec 15 16:28:45 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY